The expression of ProGRP and the precursor of gastrin-releasing peptide with high stability, have been confirmed to be elevated in lung cancer patients, while malignant tumors can produce ProGRP to promote tumor reproduction and metastasis in an autocrine manner [2]. Here, GRP is linked to neoplasm.